PETS
PetMed Express, Inc.
PETS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow.
PETS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Weak | |
| Strong |
PETS's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
PETS PE Valuation
PETS has no meaningful PE right now: it lost money over the past year.
PETS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect PETS's losses to grow, with revenue declining.
PETS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.27 | +$1.38 |
| Q2 2026 | -$1.37 | +$0.76 |
| Q1 2026 | -$2.74 | -$2.44 |
| Q4 2025 | -$3.12 | -15700% |
| Q3 2025 | -$2.65 | -$2.60 |
| Q2 2025 | -$2.13 | -$2.00 |
| Q1 2025 | -$0.30 | +$0.07 |
| Q4 2024 | $0.02 | +$0.17 |
PETS lost $1.27 per share over the past year, a smaller loss than the year before.
PETS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35.8M | -19% |
| Q2 2026 | $41M | -20% |
| Q1 2026 | $42.8M | -16% |
| Q4 2025 | $40.7M | -23% |
| Q3 2025 | $44.4M | -26% |
| Q2 2025 | $51.2M | -25% |
| Q1 2025 | $50.8M | -24% |
| Q4 2024 | $53M | -19% |
PETS's revenue has slid since its 2020 peak: $36M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -18% | +0.9 points |
| Q2 2026 | -15% | +52 points |
| Q1 2026 | -13% | -1.4 points |
| Q4 2025 | -26% | -25 points |
| Q3 2025 | -19% | -20 points |
| Q2 2025 | -67% | -73 points |
| Q1 2025 | -12% | -6.1 points |
| Q4 2024 | -0.8% | +3.9 points |
PETS's operating margin was −18% last quarter, up 0.9 points from the same quarter a year ago.
PETS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6M | +$3.2M |
| Q2 2026 | -$8.3M | +$5.2M |
| Q1 2026 | -$5.5M | -218% |
| Q4 2025 | -$9.2M | -$7.2M |
| Q3 2025 | -$4.8M | -178% |
| Q2 2025 | -$13.6M | -$4.4M |
| Q1 2025 | $4.6M | -21% |
| Q4 2024 | -$1.9M | +$1.8M |
PETS has burned cash in seven of the last eight quarters: −$25M over the past year, against −$16M the year before.
PETS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.8% | -610K shares |
| 1 year | +0.9% | +183K shares |
| 3 years | +1.4% | +292K shares |
| 5 years | +2.5% | +504K shares |
| Available history | +5.4% | +1.1M shares |
PETS has 21M diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $1,000 |
| Q4 2019 | — |
PETS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -9.9x | Net Cash |
| Q4 2024 | -6.7x | Net Cash |
| Q3 2024 | -10.3x | Net Cash |
| Q2 2024 | -8.4x | Net Cash |
| Q4 2023 | -22.5x | Net Cash |
| Q3 2023 | -14.6x | Net Cash |
| Q2 2023 | -12.6x | Net Cash |
| Q1 2023 | -10.9x | Net Cash |
PETS has more cash than debt.
PETS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 23.8 | Oversold |
| Stochastic | 5.8 | Oversold |
PETS's weekly RSI is 24 (oversold) and its Stochastic is 6 (oversold).
PETS PE vs Healthcare Sector
| Metric | PETS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
PETS has no meaningful PE right now: it lost money over the past year.
PETS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.25 | 21% below |
| 20 week MA | $1.62 | 39% below |
| 50 week MA | $2.19 | 55% below |
| 100 week MA | $2.86 | 65% below |
| 200 week MA | $5.88 | 83% below |
PETS is in a downtrend: it's below all five of its weekly moving averages, and 83% below its 200-week average.
PETS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.1 | $33.8 | +46% |
| 2021 | $33.8 | $26.4 | -22% |
| 2022 | $26.4 | $18.1 | -31% |
| 2023 | $18.1 | $7.56 | -58% |
| 2024 | $7.56 | $5.16 | -32% |
| 2025 | $5.16 | $3.47 | -33% |
| 2026 YTD | $3.47 | $0.99 | -71% |
PETS has finished five years in a row lower, and it's down 71% so far in 2026.